Apixaban after acute coronary syndrome in patients with heart failure: insights from the APPRAISE-2 trial

被引：0
|
作者：
Cornel, J. [1 ]
James, S. [2 ]
Lopes, R. D. [3 ]
Mohan, P. [4 ]
Neely, M. [3 ]
Amerena, J. [5 ]
Huo, Y. [6 ]
Alexander, J. H. [3 ]
Harrington, R. A. [3 ]
Wallentin, L. [2 ]
机构：
[1] Med Ctr Alkmaar, Alkmaar, Netherlands
[2] Uppsala Univ, UCR Uppsala Clin Res Ctr, Uppsala, Sweden
[3] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27706 USA
[4] Bristol Myers Squibb Co, Princeton, NJ USA
[5] Barwon Hlth, Geelong, Vic, Australia
[6] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [1] Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial
    Sherwood, Matthew W.
    Lopes, Renato D.
    Sun, Jie Lena
    Liaw, Danny
    Harrington, Robert A.
    Wallentin, Lars
    Laskowitz, Daniel T.
    James, Stefan K.
    Goodman, Shaun G.
    Darius, Harald
    Lewis, Basil S.
    Gibson, C. Michael
    Pieper, Karen S.
    Alexander, John H.
    AMERICAN HEART JOURNAL, 2018, 197 : 1 - 8
  • [2] APIXABAN FOLLOWING ACUTE CORONARY SYNDROMES AMONG PATIENTS WITH PRIOR STROKE: INSIGHTS FROM THE APPRAISE-2 TRIAL
    Sherwood, Matthew
    Lopes, Renato
    Sun, Jie-Lena
    Harrington, Robert
    Wallentin, Lars
    Laskowitz, Daniel T.
    James, Stefan
    Goodman, Shaun
    Darius, Harald
    Lewis, Basil
    Liaw, Danny
    Gibson, C. Michael
    Alexander, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A195 - A195
  • [3] Apixaban Plus Mono versus Dual Antiplatelet Therapy After Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial
    Hess, Connie N.
    James, Stefan
    Wojdyla, Daniel M.
    Lopes, Renato D.
    Liaw, Danny
    Hagstrom, Emil
    Bhatt, Deepak L.
    Husted, Steen
    Goodman, Shaun G.
    Lewis, Basil S.
    Verheugt, Freek W.
    De Caterina, Raffaele
    Ogawa, Hisao
    Wallentin, Lars
    Alexander, John H.
    CIRCULATION, 2014, 130
  • [4] Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes Insights From the APPRAISE-2 Trial
    Hess, Connie N.
    James, Stefan
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Neely, Megan L.
    Liaw, Danny
    Hagstrom, Emil
    Bhatt, Deepak L.
    Husted, Steen
    Goodman, Shaun G.
    Lewis, Basil S.
    Verheugt, Freek W. A.
    De Caterina, Raffaele
    Ogawa, Hisao
    Wallentin, Lars
    Alexander, John H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (07) : 777 - 787
  • [5] Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial
    Sharma, Abhinav
    Hagstrom, Emil
    Wojdyla, Daniel M.
    Neely, Megan L.
    Harrington, Robert A.
    Wallentin, Lars
    Alexander, John H.
    Goodman, Shaun G.
    Lopes, Renato D.
    AMERICAN HEART JOURNAL, 2019, 215 : 106 - 113
  • [6] The phase 3 APPRAISE-2* Trial of apixaban in patients with ACS** has been halted
    Reactions Weekly, 2010, 1330 (1) : 4 - 4
  • [7] Management and clinical consequences of major bleeding in high-risk patients following an acute coronary syndrome. Is aspirin the problem? Insights from the APPRAISE-2 trial
    Hagstrom, E.
    Wojdyla, D.
    Neely, M. L.
    Stevens, S. R.
    Harrington, R. A.
    Wallentin, L.
    Alexander, J. H.
    Goodman, S. G.
    Lopes, R. D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 861 - 862
  • [8] Intracranial hemorrhage in acute coronary syndrome: incidence, predictors, and outcomes from APPRAISE-2, PLATO, and TRACER
    Mahaffey, K. W.
    Horton, J.
    Alexander, J. H.
    Tricoci, P.
    Harrington, R. A.
    Wallentin, L.
    EUROPEAN HEART JOURNAL, 2013, 34 : 23 - 23
  • [9] Evaluating Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes After an Acute Coronary Syndrome: Insights From the EXAMINE Trial
    Sharma, Abhinav
    Cannon, Christopher P.
    White, William B.
    Liu, Yuyin
    Zannad, Faiez
    CIRCULATION, 2017, 136
  • [10] EFFECT OF APIXABAN ON COAGULATION ACITVITY BIOMARKERS FOLLOWING ACUTE CORONARY SYNDROME: LESSONS FROM THE APPRAISE TRIAL
    Becker, Richard C.
    Alexander, John H.
    Barrett, YuChen
    Yang, Honqqui
    Wang, Jessie
    Wallentin, Lars
    Harrington, Robert A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
12345